Back
ProShares UltraShort FTSE China 50 Vs. Denali Therapeutics Industry Stock Comparison
Buy
60
FXP
ProShares UltraShort FTSE China 50
Last Price:
29.08
Seasonality Move:
-9.72%
Buy
56
DNLI
Denali Therapeutics
Last Price:
31.75
Seasonality Move:
17.79%
Buy
60
ProShares UltraShort FTSE China 50 (FXP)
is a Buy
Is ProShares UltraShort FTSE China 50 a Buy, Sell or Hold?
- The current ProShares UltraShort FTSE China 50 [FXP] share price is $30.49. The Score for FXP is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- FXP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $30.76. The Score for DNLI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FXP Stock Price Chart
What is ProShares UltraShort FTSE China 50's stock price today?
-
The ProShares UltraShort FTSE China 50 share price today is $30.49
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FXP is experiencing buying pressure, which is a positive indicator for future bullish movement.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $30.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing selling pressure, which indicates risk of future bearish movement.
FXP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 45.76 | Sell |
| Chaikin Money Flow: | 883 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.99 - 31.69) | Sell |
| Bollinger Bands (100): | (28.25 - 31.95) | Buy |
DNLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.79 | Buy |
| Relative Strength Index (14 RSI): | 78.12 | Buy |
| Chaikin Money Flow: | -939708 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.39 - 28.19) | Buy |
| Bollinger Bands (100): | (19.07 - 25.27) | Buy |
FXP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.32 | Sell |
| 20-day SMA: | 30.83 | Sell |
| 50-day SMA: | 31.11 | Sell |
| 200-day SMA: | 35.33 | Sell |
| 8-day EMA: | 30.97 | Sell |
| 20-day EMA: | 31.05 | Sell |
| 50-day EMA: | 31.04 | Sell |
| 200-day EMA: | 33.2 | Sell |
DNLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.69 | Buy |
| 20-day SMA: | 26.4 | Buy |
| 50-day SMA: | 24.37 | Buy |
| 200-day SMA: | 20.59 | Buy |
| 8-day EMA: | 29.03 | Buy |
| 20-day EMA: | 26.97 | Buy |
| 50-day EMA: | 24.8 | Buy |
| 200-day EMA: | 22.21 | Buy |
ProShares UltraShort FTSE China 50 Earnings Growth & FXP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.
ProShares UltraShort FTSE China 50 Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Denali Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||